Increasing prevalence of cardiovascular and blood-related disorders, growing geriatric population, and increasing laboratory automation are key factors contributing to high CAGR of Hemostasis Analyzers during the forecast period.
Market Size – USD 3,123.43 Million in 2019
Market Growth – CAGR of 10.4%
Market Trends – Development of high-sensitivity POC coagulation testing devices
The Global Hemostasis Analyzers Market generated worth USD 3,123.43 million in the year 2019 and is foreseen to reach a valuation of USD 6,959.72 million by 2027, rising at a 10.4% CAGR during the estimated timeframe.
Key players include-
Thermo Fisher Scientific, Siemens Healthcare, Instrumentation Laboratory Werfen Group, Roche Diagnostics, Diagnostica Stago, and Sysmex Corporation, among others.
Global Market Synopsys:
Substantial economic burden and growing prevalence of distinct blood-related diseases, and increasing healthcare spending have led to the extensive use of coagulation analyzers.
Rising blood clotting disorders frequency combined with growing individuals’ blood loss incidences during several medical procedures is highly contributing to the market growth. Moreover, rising awareness about hemostasis in developing countries and fast technological advancements in hemostasis analyzers are a few major factors impacting the growth of the industry.
Continuous innovation in diagnostic technology and rising investments in R&D by developed economies worldwide have resulted in modern instruments development, including hemostasis analyzers with high throughput. Moreover, extensive R&D spending combined with the increasing awareness regarding the forefront technologies is influencing the market growth. Besides, governments are highly investing in the development of healthcare infrastructure. Additionally, several emerging countries are experiencing a rapid shift in the facilities of healthcare, along with focusing on setting up and acquiring modified diagnostic equipment. Such factors are fueling the market growth. However, slow adoption of medical devices coupled with stringent policies for such devices validation in developing economies, and high cost of analyzers are posing challenges in the market growth.
Hemostasis analyzers have been crucial in the field of military. Hemorrhage is the primary cause of fatality in combat, and after civilian trauma, this remains responsible for preventable death. In the past ten years, massive hemostatic agents’ upgradation has resulted in the innovation of dressings, replacing the care standard—gauze in the compressible hemorrhage. Such advancements have influenced ample hemostatic products, used in the civilian and combat sector. These developments are anticipated to positively impact the growth of the market.
Get a FREE Report Sample with Table of Contents and Figures @ https://www.reportsanddata.com/sample-enquiry-form/2208
Further key findings from the report suggest
- Increasing geriatric population and rising spending in healthcare are a few of the major factors supporting the market growth.
- The regional segment of North America accounts for 34.3% of share in the global market and is forecasted to retain the trend in the coming years. Fast development in healthcare infrastructure, rising cases of hemostasis disorders, and increasing activities relating to research and development are contributing substantially to the region’s growth.
- The mechanical sub-segment is projected to exhibit steadfast growth along with the highest share, owing to its high accuracy and low cost.
- Production of completely automated analyzers grants lucrative avenues for new players in the market. For example, in 2014, Symantec inaugurated the Automated Blood Coagulation Hemostasis Analyzers CS-2500, employed with the transmitted multi-wavelength light detection system.
Market Segmentation and Regional Analysis
For the purpose of this report, Reports and Data has segmented the Global Hemostasis Analyzers Market on the basis of product, test, technology, end-use, and region:
Product Outlook (Revenue, USD Million; Volume, Kilo Tons; 2017–2027)
- Analyzer for Point-of-care testing
- Clinical laboratory analyzer
- Standards, Controls, and Calibration
- Automated Systems
- Semi-Automated Systems
Test Outlook (Revenue, USD Million; Volume, Kilo Tons; 2017–2027)
- Prothrombin Time
- Activated partial Thromboplastin Time
- Activated Clotting Time
- D Dimer
- Platelet Function
- Anti-factor Xa
- Heparin & Protamine response Test for ACT
Technology Outlook (Revenue, USD Million; Volume, Kilo Tons; 2017–2027)
End-Use Outlook (Revenue, USD Million; Volume, Kilo Tons; 2017–2027)
- Diagnostic Centers
- Research Institutes
Early Diners Are Offered Free Customization
Get Attractive Discount on “Hemostasis Analyzers Market – Forecast to 2026” @ https://www.reportsanddata.com/discount-enquiry-form/2208
Regional Outlook (Revenue, USD Million; Volume, Kilo Tons; 2017–2027)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of Middle East & Africa
Table of Contents:
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018 – 2026
Chapter 3. Indicative Metrics
3.1. Rising prevalence of bleeding disorders
3.2. Increasing incidences of hemostasis
3.3. Rising need for safe blood screening across the globe
Chapter 4. Hemostasis Analyzers Segmentation & Impact Analysis
4.1. Hemostasis Analyzers Segmentation Analysis
4.2. Hemostasis Analyzers Market Value Chain Analysis, 2016-2026
4.3. Regulatory framework
4.4. Hemostasis Analyzers Market Impact Analysis
4.4.1. Market driver analysis
220.127.116.11. Rising demand for laboratory automation
18.104.22.168. Rising awareness regarding hemostasis and other bleeding disorders
4.4.2. Market restraint analysis
22.214.171.124. High cost of analyzers
126.96.36.199. Limited adoption in some regions
Click on the Link to Read Key Highlights of the Report and Look at Projected Trends for Years to Come: https://www.reportsanddata.com/report-detail/hemostasis-analyzers-market
Insights into Our Other Trending HealthCare Reports:
Digital Prescription Technology Market Size, Growth & Analysis, By Product, (Integrated Solutions, Standalone Solutions, Service) By Delivery Mode (Web, Cloud, On-premise), and By End-User (Office-based Physicians, Hospital, Pharmacy), Forecasts to 2027
Leishmaniasis Treatment Market Analysis, By Disease Type (Cutaneous Leishmaniasis, Mucosal Leishmaniasis, and Visceral Leishmaniasis), By Pathological Tests (Serological Tests, Parasitological Evaluation), By Therapy Type (Drug Therapy, Non-Drug Therapy), By End User (Hospitals, Clinics, Diagnostic Laboratories), Forecast to 2027
Non-Invasive Brain Trauma Monitoring Devices Market Size, Share and Analysis By Type (Monitoring Devices, Accessories) By Application (Traumatic Brain Injuries, Parkinson, Headache disorders, Epilepsy, Other Applications) By End-User, Forecast to 2027
Ask for your specific company profile and country level customization on reports.
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Head of Business Development
40 Wall St. 28th floor New York City
NY 10005 United States
Direct Line: +1-212-710-1370
Facebook | LinkedIn | Twitter | Blogs